S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ARWR Arrowhead Pharmaceuticals Inc

20.24

-0.24 (-1.17%)

08 Feb 2025 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Arrowhead Pharmaceuticals Charts.

Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Arrowhead Pharmaceuticals Charts.

Arrowhead Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 8 February 2025 (1 day ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Saturday 8 February 2025 (1 day ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 28 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 24 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Guidewire Software Set to Join S&P MidCap 400; Arrowhead Pharmaceuticals to Join S&P SmallCap 600
Thursday 23 January 2025 (2 weeks ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 7 January 2025 (1 month ago) • Edgar (US Regulatory)

More Arrowhead Pharmaceuticals Inc News Articles

S&P ASX 300 Metals and M...

Verizon Communications

National Australia Bank

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions